Le Lézard

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. ("LIR" or the "Company")is pleased to announce ...
pharmaphorum

Otsuka preps for July decision on centanafadine for ADHD

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...

Tianjin Fuqin Science & Technology: Global Leading Heating Patch Manufacturer

TIANJIN, TIANJIN, CHINA, January 27, 2026 /EINPresswire.com/ -- Navigating the opening months of 2026, the global ...

Lir Life Sciences Corp.: LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based ...

VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim resu ...